IntelliChem Announces Release of Universal ELN Solution

IntelliChem, Inc., the leading provider of intelligent electronic lab notebooks (iELN) for discovery and development, today announced the release of the IntelliChem Universal ELN solution.  


As opposed to tailored ELN solutions designed to model specific workflows for a specific user type, a universal ELN solution is designed to be flexible enough to model any scientific or non-scientific workflow. This allows the usage of an ELN solution to span an even broader user audience, increasing productivity and protecting intellectual property across the enterprise. And unlike many of the universal or “nonspecific” ELN products available today, the IntelliChem Universal ELN is fully chemically aware, allowing content such as chemical structures, materials, and analytical data to be captured, viewed, and searched.

The IntelliChem Universal ELN is now an integrated component of each IntelliChem product suite, adding value to the IntelliChem i ELN solutions tailored to meet the specific workflow requirements in drug discovery, development, formulations, analytical, and bioprocess organizations. By using its patented software framework to build the IntelliChem Universal ELN, this offering benefits from the same integrated workflow, user access control, signing/witnessing, searching, cloning, and document management capabilities available across all the IntelliChem product lines.


“ELN consumers demand products that are specific to the needs of the scientist and have a common backend infrastructure,” described Michael Elliott, President of Atrium Research & Consulting. “In many organizations there are departments with less structured processes which require only the use of a generic authoring tool. Suppliers that provide fully integrated specific and nonspecific ELN functionality are poised for market success. IntelliChem has listened to the needs of the market with the addition of this product to the IntelliChem 
i ELN suite.”

                                                                  

“By providing a complete suite of tailored, intelligent ELN solutions across discovery and development, along with the new IntelliChem Universal ELN, IntelliChem is able to provide customers with unparalleled functional breadth and the ability to achieve the broadest business benefits,” explained Matt Wallach, Vice President of Marketing and Product Management at IntelliChem. “For the first time, pharmaceutical and biotechnology companies can deploy a single intelligent ELN solution across their entire global R&D organization.”

The IntelliChem Universal ELN solution is available as a standalone application or as an integrated component of all other IntelliChem product suites.

About Intelligent Electronic Laboratory Notebooks

Intelligent electronic lab notebooks (i ELN) not only allow companies to replace paper laboratory notebooks with an electronic, searchable system, but they also provide collaborative decision-support tools to help scientists and engineers make better decisions. Only intelligent ELN systems can deliver the benefits that pharmaceutical and biotechnology companies require to dramatically improve productivity and efficiency in their global research and development organizations.
                              

About IntelliChem

IntelliChem, Inc. is the leading provider of intelligent electronic lab notebooks (i ELN) for discovery and development. Pharmaceutical, biotechnology, and fine chemicals companies can improve productivity, enable collaboration, improve quality, and ensure regulatory compliance through the adoption of IntelliChem solutions. IntelliChem Discovery & Development Solutions (IDS) were developed and validated through partnership with six major pharmaceutical companies, including Merck & Co., Pfizer, and Bristol-Myers Squibb. IntelliChem is a privately held company with headquarters and development facilities located in Bend, Oregon. For more information, visit www.intellichem.com .